RAC 0.60% $1.69 race oncology ltd

Ann: Zantrene AML trial in Israel advances to Phase 2, page-148

  1. 8,518 Posts.
    lightbulb Created with Sketch. 1397
    If RAC had never existed, COH would by now have conducted clinical trials using CS-1.
    There would have been no legal issues.
    There is no way that CS-1 would have been lost.

    The only things that would have been lost are the marketing name "Zantrene" (so what) and the cardioprotection discovery (a big loss).
    Last edited by IndexInvestor: 15/07/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.69
Change
0.010(0.60%)
Mkt cap ! $287.1M
Open High Low Value Volume
$1.69 $1.70 $1.65 $89.01K 53.2K

Buyers (Bids)

No. Vol. Price($)
1 2342 $1.69
 

Sellers (Offers)

Price($) Vol. No.
$1.70 5 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.